Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Nasopharyngeal Carcinoma 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Thymoma 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Piebaldism 1 Gastrointestinal Stromal Tumors 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced or Metastatic Solid Tumors 1

Interventions

Radiotherapy 3 pembrolizumab 2 fludarabine 2 Drug Therapy 2 Cyclophosphamide 2 zimberelimab 1 lenvatinib 1 envafolimab 1 Thymectomy 1 Thoracic Surgery, Video-Assisted 1 Radiotherapy, Adjuvant 1 Proton Therapy 1 Paclitaxel 1 Methylprednisolone 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Carboplatin 1 Bupivacaine 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thymoma × envafolimab × Clear all

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡